Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

WHAM launches 2025 Edge Awards to support early-career researchers in women’s health

By Brian Buntz | September 13, 2025

Women’s Health Access Matters (WHAM) has opened nominations for its 2025 Edge Awards, providing $25,000 grants to early-career investigators studying sex-based differences in health outcomes.

The awards target research in autoimmune diseases, brain health, cancer and heart health, conditions that often affect women differently than men. For the first time, WHAM is also accepting proposals on healthspan, bone and muscle health, and novel treatments for endometriosis, menopause and polycystic ovary syndrome. Applications can incorporate AI and secondary data analysis.

Nominations come from WHAM’s Research Collaborative, a network of more than 100 scientists and physicians from leading institutions. The Scientific Advisory Board, including experts from Harvard Medical School, Yale and Northwestern University, will select recipients. Notifications are set for Oct. 29, with a virtual forum and awards presentation on Nov. 18.

The program, started in 2022, addresses a funding gap for junior researchers who lack preliminary data required by many federal grants. “Too many promising research ideas go unfunded simply because they are too early-stage for traditional grantmaking… early investment in bold ideas—and in the brilliant minds behind them—is how we drive progress in women’s health,” said Dr. Anula Jayasuriya, WHAM’s chief scientific officer.

This comes amid a wave of 2025 funding initiatives for women’s health. ARPA-H’s Sprint for Women’s Health has awarded about $110–$113M to ~24 teams. The EQT Foundation’s Breakthrough Science Grants offer €25k–€100k for women’s-health projects. The Foundation for Women’s Health prioritized autoimmune disease and uterine cancer in its 2025 RFA.

Such efforts highlight growing recognition of underinvestment in sex-specific research. Diseases like heart disease and Alzheimer’s strike women harder, yet studies historically default to male subjects. WHAM’s analysis shows that $350 million in women’s health research could yield $14 billion in economic returns through better outcomes and lower costs.

WHAM, a nonprofit founded by Carolee Lee, convenes leaders to advance women’s health from lab to policy. Its Investigator’s Fund drives private investment in these areas.


Filed Under: Uncategorized

 

About The Author

Brian Buntz

As the pharma and biotech editor at WTWH Media, Brian has almost two decades of experience in B2B media, with a focus on healthcare and technology. While he has long maintained a keen interest in AI, more recently Brian has made making data analysis a central focus, and is exploring tools ranging from NLP and clustering to predictive analytics.

Throughout his 18-year tenure, Brian has covered an array of life science topics, including clinical trials, medical devices, and drug discovery and development. Prior to WTWH, he held the title of content director at Informa, where he focused on topics such as connected devices, cybersecurity, AI and Industry 4.0. A dedicated decade at UBM saw Brian providing in-depth coverage of the medical device sector. Engage with Brian on LinkedIn or drop him an email at [email protected].

Related Articles Read More >

American Society of Gene & Cell Therapy and Orphan Therapeutics Accelerator partner for medicines for rare diseases
Novartis picks Salesforce’s Agentforce as pharma bets big on AI agents
Ajinomoto CELLiST Korea launches CELLiSTTM AAV production supplement 1 to improve gene therapy manufacturing efficiency
Lilly’s triple agonist delivers up to 71.2 lbs of weight loss in Phase 3 trial
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2026 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE